Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

被引：0
|
作者：
Prezotti, Alessandra N. L. [1 ,2 ]
Villaca, Paula Ribeiro [3 ]
Rocha, Debora M. C. [2 ]
Orletti, Maria P. S. V. [2 ]
Lourenco, Christiane [2 ]
Yamaguti Hayakawa, Gabriela G. [1 ,4 ]
Ozelo, Margareth C. [1 ,4 ]
机构：
[1] Univ Estadual Campinas, Sch Med Sci, Dept Internal Med, UNICAMP, Campinas, SP, Brazil
[2] HEMOES, Hemoctr Espirito Santo, Vitoria, ES, Brazil
[3] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, SP, Brazil
[4] Univ Estadual Campinas, Hemoctr UNICAMP, Campinas, SP, Brazil
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-171028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference?
    Mantovani, Lorenzo G.
    Rota, Matteo
    Cortesi, Paolo
    Steinitz, Katharina
    Reininger, Armin
    Gringeri, Alessandro
    BLOOD, 2015, 126 (23)
  • [32] Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review
    Hassan, S. .
    Cannavo, A.
    Gouw, S. C.
    Rosendaal, F. R.
    van der Bom, J. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (06) : 1055 - 1068
  • [33] Effect of plasma-derived or recombinant factor VIII on inhibitor development: a systematic review
    Iorio, A.
    Halimeh, S.
    Goldenberg, N.
    Kenet, G.
    Young, G.
    Brandao, L.
    HAEMOPHILIA, 2010, 16 : 74 - 74
  • [34] Different inhibitor incidence for individual factor VIII concentrates in 1076 previously untreated patients with severe hemophilia A: data from the PedNet cohort
    Fischer, Kathelijn
    Carcao, Manuel
    Male, Christoph
    Ranta, Susanna
    Pergantou, Helen
    Kenet, Gili
    Kartal-Kaess, Mutlu
    Koenigs, Christoph
    Carvalho, Manuela
    Alvarez, Maria Teresa
    Brakenhoff, Timo
    Chambost, Herve
    van den Berg, H. Marijke
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (03) : 700 - 703
  • [35] Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate
    Gringeri, A
    Monzini, M
    Tagariello, G
    Scaraggi, FA
    Mannucci, PM
    HAEMOPHILIA, 2006, 12 (02) : 128 - 132
  • [36] French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII:: Incidence of inhibitor and evaluation of immune tolerance
    Rothschild, C
    Laurian, Y
    Satre, EP
    Derlon, AB
    Chambost, H
    Moreau, P
    Goudemand, J
    Parquet, A
    Peynet, J
    Vicariot, M
    Beurrier, P
    Claeyssens, S
    Durin, A
    Faradji, A
    Fressinaud, E
    Gaillard, S
    Guérin, V
    Guérois, C
    Pernod, G
    Pouzol, P
    Schved, JF
    Gazengel, C
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (05) : 779 - 783
  • [37] Switching previously treated patients with severe or moderately severe hemophilia B from A plasma-derived to a recombinant factor IX (BAX326) treatment
    Trujillo, M. H. Solano
    Stasyshyn, O.
    Rusen, L.
    Lamas, J. L.
    Urasinski, T.
    Perina, F. G.
    Knowlton, W. B.
    Valenta-Singer, B.
    Pavlova, B. G.
    Abbuehl, B. E.
    HAEMOPHILIA, 2014, 20 : 68 - 69
  • [38] Multicenter study of inhibitor development surveillance in previously treated hemophilia A patients exposed to recombinant DNA derived factor VIII concentrates
    de Biasi, R
    Rocino, A
    Mannucci, PM
    Santagostino, E
    Morfini, M
    Mazzucconi, MG
    Baudo, F
    Castaman, G
    Iannaccaro, P
    THROMBOSIS RESEARCH, 1998, 91 (03) : S96 - S96
  • [39] Lower inhibitor risk of plasma-derived factor VIII concentrates versus recombinant factor VIII concentrates in patients with severe haemophilia A : result from SIPPET study and comments
    Biron-Andreani, Christine
    Diaz, Isabelle
    Navarro, Robert
    Schved, Jean-Francois
    HEMATOLOGIE, 2019, 25 (02): : 93 - 99
  • [40] Evidence for increased inhibitor incidence in children with severe hemophilia a treated with recombinant factor VIII products: a systematic review & meta-analysis
    Halimeh, S.
    Bindlingmaier, C.
    Ettinghausen, Escuriola C.
    Goldenberg, N.
    Holzhauer, S.
    Kenet, G.
    Kurnik, K.
    Manner, D.
    Nowak-Goettl, U.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 247 - 247
12345